|
Dylan Scott's September 17, 2026 article in Vox reminds us of the very-much-not-okay state of insulin pricing today. Rationing continues. It does not need to. We can do better.
I love a fine editorial illustration. Art with a day job. "Insulin Price" from Daniel Garcia is from 2023, but it rings true today.
0 Comments
Hugh Hayden's "Fairy Tale" was included in the Davidson College group show Alternative Medicine: Healing Remedies for Harmful Times, curated by John Corso-Esquivel and Lia Newman. I wish I had been able to see this exhibit in North Carolina! It ran from February 11 to April 14, 2026.
As with other essential medicines, the Descovy pills for preventing and treating HIV are worth more than diamonds or gold to those who need them. This work is brilliant on multiple levels. Hugh Hayden is represented by Lisson Gallery and C L E A R I N G. If you are near Brooklyn Art Haus this weekend you belong at this festival. Ian Goldstein, Emily Menez and One Nation, Overcharged have organized a fun and thought-provoking lineup in New York City.
Last night I enjoyed the July 4 fireworks, "Feuerwerk" in a jam-packed public park with friends. We spoke German and English and kept our umbrellas handy for the light rain. It was a magnificent display.
Skyrocket is still the go-to word for soaring drug prices. A skyrocket is a type of firework that rises quickly before delivering. Here's a piece from the Skyrocket collage series. It includes texts from drug formulary exclusions and currency and is, for obvious reasons, on a paper tube. Let's light the sky with solutions and ingenuity. Let's be driven by access for patients and research support instead of shareholders and corporate control. The second Saturday in May is World Collage Day. Around the world activities, exhibitions and community goings-on for May 9, 2026 celebrate the art form.
My response is a collage meditation on the green cross - an international symbol for pharmacy. I am a true fan of pharmacists and techs who provide medicines and advice day after day. Cheers to you! I am not a fan of the upstream barriers to getting these medications. Lack of access erodes our trusted go-to space for relief. The threshold of a pharmacy should be one all can enter. "Drug Store Blues" refers to such barriers, and to the still-illuminated promise the symbol holds. I asked iconographer Celeste Lauritsen to respond to the crisis in drug pricing and access in the United States. Instead of overt images of the pharmaceutical industry’s behavior, she brings us Luke. Written on wood, his figure shares space with a Caduceus and a map of the U.S. Here, the patron saint of artists and physicians waits for us. Why?
Pharmaceutical companies and pharmacy benefit managers thrive amidst an outdated patent system and corporate monopolies. With one in four American adults struggling to afford prescription drugs, the issue of access to medicines touches households in every county of every state and territory. The icon’s map reminds me of "Adios Map" by the late artist and curator Jaune Quick-to-See Smith. When I first saw the mixed-media painting in the East Building at the National Gallery of Art in Washington, D.C. I felt an immediate kinship to Lauritsen’s icon. Smith’s Adios Map assembles goodbye phrases from different languages referring to stolen land across a grid of America’s mainland. Both imply. Both wait. Might St. Luke The Physician ask us to consider our most immediate territory? Our bodies? Essential medicines intercede – for minutes or decades – when we reach our limits. They keep us breathing. They stop cells from lethal over-replication. They digest food, control blood glucose, prevent blood clots and fight infections (if, and only if we can afford them). What about the organic Caduceus on the right? It’s a familiar symbol for medical organizations and publications. Asserting that the Rod of Aesculapius is “the only true symbol of medicine” is a bit of a purity sport for some people. The Rod or Staff entwined by one snake is identified with medicine. Aesculapius was, after all, the Greek god of medicine. These two symbols, however, have taken on a nearly interchangeable meaning in visual culture today. And it is the Caduceus (wings, two snakes) that suits both the delivery of medical treatment and distribution of medicines today. The Caduceus is the Herald Wand for Hermes, the Greek god of commerce. It fits. Or, in the language of corporate healthcare, it aligns. Icons are associated with the veneration of a saint or a narrative scene. To venerate is to honor. It also means, simply, to respect. When will we appeal to the brilliant promise of the pharmaceutical industry to respect us? Instead of skyrocketing prices, where are skyrocketing ethics? Skyrocketing cooperation? Major pharmaceutical companies spend more on shareholder dividends, executive compensation and stock buybacks than they do on research and development. Add on spending for advertising and congressional lobbying, and the R&D proportion shrinks even further. What we expect from every politician representing us and shaping policy matters. The valuable territory we cede to the pharmaceutical industry matters. The status quo is not inevitable. We can do better. Lauritsen’s choice of Luke is no accident. What does the patron saint of artists and physicians wait for us to see? To change? If lawmakers would truly put themselves in the shoes of constituents needing medicines of any kind, they would vote accordingly. We would not waste time pointing out the institutional monopolies and obvious absurdities undermining our ability to make basic decisions. Sigh. Even the right to birth control is being called into question in this country. A chic, straightforward work of art on the topic is "In Our Shoes" by Michele Pred. Cheers to you, Michele. Thank you. For a concise reminder of the subtle, powerful factors jeopardizing contraceptive access I recommend Deborah Tuerkheimer’s essay “Threats to Contraception” in the November 2025 issue of the Stanford Law Review.
Michele Pred is represented by Nancy Hoffman Gallery in New York, NY. This Jen Sorensen cartoon from 2012 still resonates today. Attitudes toward medicine access are like attitudes toward access to healthcare in general. For decision-makers who don't have to worry about getting a doctor appointment, or a prescription refill, or needed treatment, it's abstract. These lawmakers are the ones with no skin in the game. Voters are decision-makers, too. Really. Truly. Seriously. In 2026 may we pay attention. May we tell the difference. May we make good decisions for the communities (from local to global) that we are a part of.
In December, at the end of 2025, the AMA Journal of Ethics stops publication. I am gutted to hear it.
This open-access journal meets a sweet spot in health professions education. A rigorously composed, insightful cocktail of art, ethics and healthcare, it is free to all interested readers. The journal started over 25 years ago. It asks good questions. Tricky ones. Fascinating, practical ones. In the topics over the years, access to medicines comes up naturally, in various contexts. I toast every member of the editorial team (an editor is a mixologist, after all), every editorial fellow, every artist and author and podcast interviewer. I toast the journal’s collaboration with the School of the Art Institute of Chicago. Here’s to you! A toast to AMA Journal of Ethics is truly a toast to public health. Content will be archived at the site. Visit AMA Journal of Ethics. Read the November 14, 2025 MedPage Today article by Matthew Wynia, MD, MPH, and Kayhan Parsi, JD, PhD. If you're in New Orleans, swing by the Kolaj Institute Gallery for Big Orange Monster: An Emergency Collage Exhibition. The show runs from September 10 through October 18, 2025 and features contributions from 128 artists in 13 countries. Curated by Ric Kasini Kadour, these collages gather witty, scary, uncertain, thoughtful responses to all manner of orange monsters in our midst.
I could not help but think of the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, known as the Orange Book. This 'book' is itself a good thing, but improper listings by drugmakers contribute to abuse of the patent system and wild-high prices. The team at I-MAK (Initiative for Medicines, Access and Knowledge) has a database and information about the issue, as well as constructive solutions for improving the patent system. My collage entry in the show is called "Devil in the Details." Visit the Kolaj Institute Gallery at 2374 Saint Claude Avenue (Suite 230) in New Orleans. |
BP&theBAn arts blog advocating for access to essential medicines Archives
October 2026
Categories |

RSS Feed